平民创伤中未冰冻液态血浆输注:一项全国倾向匹配分析
本研究基于创伤质量改进计划2017年数据,纳入成人(≥18岁)创伤后早期(≤4小时)接受血浆输注的患者,按1:2倾向评分匹配,比较未冰冻液态血浆(LQP)与解冻新鲜冰冻血浆(FFP)的结局。共匹配107例LQP与214例FFP患者(平均年龄48±19岁,73%男性,中位损伤严重度评分27[23-41],42%处于休克状态)。LQP组首次血浆输注中位时间显著短于FFP组(54[28-79]分钟 vs 98[59-133]分钟,p<0.001)。24小时死亡率(2.8% vs 3.7%,p=0.664)和院内死亡率(16.8% vs 20.1%,p=0.481)无差异,主要并发症(15.9% vs 21.5%,p=0.233)和住院时间(12[6-21]天 vs 12[6-23]天,p=0.826)亦无差异。作者认为LQP在创伤复苏中安全有效,且因储存时间更长和即时可用性,有潜力扩展输血储备。
要点
- 成人创伤患者早期(≤4小时)输注LQP较FFP首次血浆输注时间显著更短:54[28-79]分钟 vs 98[59-133]分钟,p<0.001。
- 倾向匹配后LQP组与FFP组24小时死亡率(2.8% vs 3.7%,p=0.664)和院内死亡率(16.8% vs 20.1%,p=0.481)无显著差异。
- 主要并发症发生率LQP组15.9% vs FFP组21.5%(p=0.233),住院时间12[6-21]天 vs 12[6-23]天(p=0.826),均无显著差异。
- 匹配队列中位输注量为PRBC 4[2-6]单位、LQP或FFP 2[1,3]单位、血小板1[0-1]单位。
- 作者认为LQP在创伤复苏中安全有效,且因储存时间更长和即时可用性,有潜力扩展输血储备。
适用人群与场景
- 成人(≥18岁)创伤患者,在创伤质量改进计划2017年数据库中接受早期(≤4小时)血浆输注。
- 匹配队列特征:平均年龄48±19岁,73%为男性,中位损伤严重度评分27[23-41],42%处于休克状态,22%为穿透伤,31%需手术止血。
研究设计与关键结果
- 研究类型:基于创伤质量改进计划2017年的全国倾向匹配分析;107例接受LQP的患者按1:2匹配214例接受FFP的患者。
- 主要终点:首次血浆输注中位时间LQP组54[28-79]分钟 vs FFP组98[59-133]分钟,p<0.001。
- 24小时死亡率LQP组2.8% vs FFP组3.7%,p=0.664;院内死亡率LQP组16.8% vs FFP组20.1%,p=0.481。
- 主要并发症LQP组15.9% vs FFP组21.5%,p=0.233;住院时间LQP组12[6-21]天 vs FFP组12[6-23]天,p=0.826。
- 匹配队列中位输注量:PRBC 4[2-6]单位,LQP或FFP 2[1,3]单位,血小板1[0-1]单位。
证据类型、等级与局限
- 证据类型:治疗性研究,证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未冰冻液态血浆在创伤患者复苏中安全有效。
- 作者认为未冰冻液态血浆因储存时间更长和即时可用性,有潜力扩展输血储备。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Never-frozen liquid plasma (LQP) was found to reduce component waste, decrease health care expenses, and have a superior hemostatic profile compared with fresh frozen plasma (FFP). Although transfusing LQP in hemorrhaging patients has become more common, its clinical effectiveness remains to be explored. This study aims to examine outcomes of trauma patients transfused with LQP compared with thawed FFP.
METHODS: Adult (≥18 years) trauma patients receiving early (≤4 hours) plasma transfusions were identified in the Trauma Quality Improvement Program 2017. Patients were stratified into those receiving LQP versus FFP. Propensity-score matching in a 1:2 ratio was performed. Primary outcome measures were mortality and time to first plasma unit transfusion. Secondary outcome measures were major complications and hospital length of stay.
RESULTS: A total of 107 adult trauma patients receiving LQP were matched to 214 patients receiving FFP. Mean age was 48 ± 19 years, 73% were male, and median Injury Severity Score was 27 [23-41]. A total of 42% of patients were in shock, 22% had penetrating injuries, and 31% required surgical intervention for hemorrhage control. Patients received a median of 4 [2-6] units of PRBC, 2 [1,3] units of LQP or FFP, and 1 [0-1] unit of platelets. The median time to the first LQP unit transfused was significantly shorter compared with the first FFP unit transfused (54 [28-79] minutes vs. 98 [59-133] minutes; p < 0.001). Rates of 24-hour mortality (2.8% vs. 3.7%; p = 0.664) and in-hospital mortality (16.8% vs. 20.1%; p = 0.481) were not different between the LQP and FFP groups. Similarly, there was no difference in major complications (15.9% vs. 21.5%; p = 0.233) and hospital length of stay (12 [6-21] vs. 12 [6-23] days; p = 0.826).
CONCLUSION: Never-frozen liquid plasma is safe and effective in resuscitating trauma patients. Never-frozen liquid plasma has the potential to expand our transfusion armamentarium given its longer storage time and immediate availability.
LEVEL OF EVIDENCE: Therapeutic, Level IV.
参考来源
- Chehab M, Ditillo M, Obaid O, et al. Never-frozen liquid plasma transfusion in civilian trauma: a nationwide propensity-matched analysis. J Trauma Acute Care Surg. 2021. PMID: 33605695. doi:10.1097/TA.0000000000003116
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。